Economic Atlas
Companies/Whitehawk Therapeutics Inc
Company profile

Whitehawk Therapeutics Inc

NASDAQ: WHWK · Healthcare · Biotechnology
PublicHQ Pacific Palisades, CACIK 0001422142Reports USD
#674 of 1,422 Healthcare companies by revenuebottom-quartile growth
EA Score
50D
Revenue TTM
$0
Rev growth YoY (TTM)
-100.0%
Net income (FY)
-$20.6M
Employees
23
as of 2026-08-13
Market cap
$268.5M
as of 2026-08-13

Financials — latest annual

SEC EDGAR · USD-normalized
ConceptUSDNativeFY
Revenue$7.1M$7.1M2025
Net income-$20.6M-$20.6M2025
Operating income-$114.4M-$114.4M2025
Total assets$150.8M$150.8M2025
Liabilities$14.5M$14.5M2025
Equity$136.3M$136.3M2025

Revenue trend

FY2018 – FY2025 · USD
FY18
FY20
FY20
FY21
FY22
FY23
FY24
FY25

Revenue by segment

Filed disclosures · FY2025
By product
Product100%
By geography

Not disclosed.

The read

What is Whitehawk Therapeutics Inc’s revenue?

Whitehawk Therapeutics Inc booked $7.1M in FY2025 revenue, contracting 73% year over year — slower than 87% of Healthcare companies we track, at a -288.3% net margin.

Peers · Healthcare
Syra Health Corp. Class A Common Stock51DMedical Imaging Corp.——T2 Biosystems, Inc.——Immunome, Inc.47DINVO Fertility, Inc.43DMedite Cancer Diagnostics, Inc.——
Key facts
CEODavid J. Lennon
SectorHealthcare
IndustryBiotechnology
HeadquartersPacific Palisades, CA
ExchangeNASDAQ: WHWK
Employees23
IPO date2017-08-01
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.